FDA Inspection 1220079 — Shandong Xinhua Pharmaceutical Co., Ltd. First Plant
The FDA completed an inspection of Shandong Xinhua Pharmaceutical Co., Ltd. First Plant on September 15, 2023 in Zibo. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 15, 2023
- Fiscal Year
- 2023
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Zibo (China)